DS
Therapeutic Areas
Connect Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Rademikibart (CBP-201) | Moderate-to-Severe Atopic Dermatitis | Phase 3 |
| CBP-307 | Moderate-to-Severe Ulcerative Colitis | Phase 2 |
| CBP-174 | Pruritus in Atopic Dermatitis | Phase 2 |
| Drug | Indication | Phase |
|---|---|---|
| Rademikibart (CBP-201) | Moderate-to-Severe Atopic Dermatitis | Phase 3 |
| CBP-307 | Moderate-to-Severe Ulcerative Colitis | Phase 2 |
| CBP-174 | Pruritus in Atopic Dermatitis | Phase 2 |